About
Helping Biotech Innovation from Market to Lab and Back
At PlexoA, our mission is to bridge the gap between cutting-edge science and successful commercialization, providing both actionable insights for immediate impact and long-term strategic guidance for sustained success.
Problem
In early-stage biotech, great science is easy to promise—but hard to prove.
Investors and innovation teams are constantly pitched bold visions: the next platform, the next breakthrough, the next cure. But beneath the buzzwords, many of these startups are built on limited data and untested science.
You want to believe in the future—but without the time or tools to dig deep, you’re left navigating complexity with uncertainty. Scientific diligence often gets rushed, inconsistent, or shaped by founder narratives rather than objective evidence.
And the cost of getting it wrong?
Wasted capital, missed timelines, and programs that stall before they ever reach patients.
Solution
At PlexoA, we know how much is at stake—and we’re here to help you get it right from the start.
We offer independent, science-led diligence and R&D advisory designed for those making high-conviction decisions in biotech. Led by scientists who’ve spent their careers in research, review, and strategy, we bridge the gap between innovation and investment clarity.
We go beyond the pitch deck to assess what really matters:
- Is the biology sound?
- Is the data strong?
- Is this science ready to translate?
With PlexoA by your side, you gain a trusted partner who understands both the excitement and the risk—so you can invest, license, or support with confidence.
Meet Our Leadership
Our team of industry veterans, scientists, and strategists combines deep technical expertise with sharp business insight. With backgrounds spanning precision oncology, biopharma consulting, and R&D due diligence, we help biotech startups, investors, and enterprises bridge the gap between innovation and commercialization.
Dr. Indrabahadur Singh
Founding Managing Director
With over 15 years of precision R&D experience in oncology, Dr. Singh is a trusted expert in life sciences market research, R&D due diligence, and biotech strategy. As an Emmy Noether DFG Grant Award Recipient, he brings deep scientific credibility paired with strategic acumen. Having navigated the complexities of biotech innovation first-hand, he excels in evaluating breakthrough science, identifying risk factors, and guiding investment and development decisions.
Dr. Anshu Singh
Chief Operating Officer
Dr. Singh has 10+ years of experience in oncology and biotech growth strategy. As an EXIST Women Grant Award Recipient, she specializes in supporting biotech companies and startups in strengthening market positioning and accelerating commercial traction. She helps early-stage ventures overcome visibility challenges, build partnerships, and scale strategically. She is dedicated to helping women-led and science-driven biotech thrive in competitive global markets.
A Trusted Partner in Life Sciences Growth
At PlexoA, we combine scientific depth with strategic foresight to support life sciences innovation at every stage. Backed by a seasoned team of researchers and biotech strategists, we deliver rigorous analytical insights and tailored guidance—empowering startups, investors, and enterprises to confidently advance from discovery to commercialization.
What Our Clients Say
”If you’re a biotech startup trying to scale, PlexoA should be your first call. Their network, advice, and business know-how helped us land key partnerships and stand out in the market.”
Client 1
COO, Biotech Scale-Up
“With PlexoA’s help, we built a smart outreach strategy and connected with the right investors. Their guidance on branding and client growth was a total game-changer.”
Client 2
Founder, AI-Powered Biotech Firm
“PlexoA’s team gave us exactly what we needed—a clear, science-backed view of the opportunity. Their due diligence helped us move forward with confidence.”
Client 3
Managing Partner, Life Sciences Venture Capital Firm